Appoints Charles Tamburello to board; 100M shares as compensation

Cannabis Bioscience International Holdings, Inc.

Charles Tamburello appointed director effective Dec 1, 2024; board expands from three to four.
Tamburello, CEO of Global Discovery Group, recruited for M&A expertise; receives no cash, 100M restricted shares.
If removed for cause or resigns before Nov 30, 2025, must return 8.33M shares per full month remaining.
Board also created a single-director Executive Committee on Nov 15, 2024, with limited authority per Colorado law.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Charles Tamburello

Director

CBIH · Cannabis Bioscience International Holdings, Inc.

Effective: 2024-12-01
Filed: November 26, 2024, 6:59 PM ET

filled the vacancy thus created with Charles Tamburello, who will serve from December 1, 2024, until the next annual meeting of shareholders.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Charles Tamburello was appointed as Director at Cannabis Bioscience International Holdings, Inc..

Action: appointed
Role: Director

Exact text from the filing

filled the vacancy thus created with Charles Tamburello, who will serve from December 1, 2024, until the next annual meeting of shareholders.

View on SEC.gov

Cannabis Bioscience International Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001683168-24-008403

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.